usace.army.mil

1-62 Air Defense Artillery Battalion to transfer authority of the US Patriot mission to 5-7 Air Defense Artillery Battalion.

POLAND — The 1st Battalion, 62nd Air Defense Artillery Regiment will transfer authority of the U.S. Patriot mission in Eastern Europe to the 5th Battalion, 7th Air Defense Artillery Regiment on June ...
usace.army.mil

US Army's 1st Battalion, 62nd Air Defense Artillery Regiment extends deployment in Poland

POLAND — The 1st Battalion, 62nd Air Defense Artillery Regiment (1-62 ADA BN), based out of Fort Cavazos, Texas, has seen its deployment in Poland extended for three additional months. This decision ...
MarketScreener

Lupin Limited Receives Tentative FDA Approval for Generic Androgel, 1.62%

Jun. 05 Lupin Gets US FDA Approval for Ranluspec Interchangeable Biosimilar for Eyesight Ailments MT Jun. 04 Lupin Limited Receives Approval from U.S. FDA for Ranluspec Ranibizumab Injection CI Jun.
BioSpace

Actavis Confirms Generic AndroGel® 1.62% Patent Challenge

PARSIPPANY, N.J., April 1, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) ...
BioSpace

Abbott Laboratories Receives U.S. FDA Approval for AndroGel(R) 1.62% to Treat Men with Low Testosterone

ABBOTT PARK, Ill., April 29, 2011 /PRNewswire/ -- Abbott (NYSE:ABT - News) announced today that the U.S. Food and Drug Administration (FDA) has approved AndroGel® (testosterone gel) 1.62%, a clear, ...